TRANSFORMING CARE FOR PATIENTS IN NEED
Using next-generation enzyme compounds Oxidien develops treatments for
secondary hyperoxaluria to ultimately prevent kidney stone disease.
We’re updating our site to better serve our visitors. Please visit again soon to see what’s new, or fill out the form below and our team will be in touch with you.
Download Oxidien’s Latest Non-confidential Deck
Oxidien Pharmaceuticals
405 Waltham St. #327
Lexington, MA 02421